138629-44-4

Basic information

• Product Name: (2R)-2-[[[(1,1-DIMETHYLETHYL)DIPHENYLSILYL]OXY]METHYL]-5-OXO-1-PYRROLIDINE
• Synonyms: (2R)-2-[[[(1,1-DIMETHYLETHYL)DIPHENYLSILYL]OXY]METHYL]-5-OXO-1-PYRROLIDINE;D-O-TBDPS-PYROGLUTAMINOL;(5R)-5-[[[(1,1-diMethylethyl)diphenylsilyl]oxy]Methyl]-2-Pyrrolidinone;(R)-5-((tert-butyldiphenylsilyloxy)methyl)pyrrolidin-2-one;(5R)-5-[[[(tert-Butyl)diphenylsilyl]oxy]methyl]-2- pyrrolidinone
• CAS NO: 138629-44-4
• Molecular Formula: C₂₁H₂₇NO₂Si
• Molecular Weight: 353.535
• Mol File: 138629-44-4.mol
• Article Data: 13

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (2R)-2-[[[(1,1-DIMETHYLETHYL)DIPHENYLSILYL]OXY]METHYL]-5-OXO-1-PYRROLIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: (2R)-2-[[[(1,1-DIMETHYLETHYL)DIPHENYLSILYL]OXY]METHYL]-5-OXO-1-PYRROLIDINE(138629-44-4)
• EPA Substance Registry System: (2R)-2-[[[(1,1-DIMETHYLETHYL)DIPHENYLSILYL]OXY]METHYL]-5-OXO-1-PYRROLIDINE(138629-44-4)

Safety Data

• Hazardous Substances Data: 138629-44-4(Hazardous Substances Data)

Usage

General Description

"(2R)-2-[[[(1,1-DIMETHYLETHYL)DIPHENYLSILYL]OXY]METHYL]-5-OXO-1-PYRROLIDINE" is a complex chemical compound with a molecular formula C24H33NO2Si. It is a pyrrolidine derivative containing a chiral center. The compound is composed of a pyrrolidine ring, a silicon-containing diphenylsilyloxy group, and a methyl ketone. This chemical is commonly used in organic synthesis and pharmaceutical research due to its unique structure and potential medicinal properties. It is important to handle and use this chemical with caution and under proper laboratory conditions.

Upstream product

• 66673-40-3 (R)-5-hydroxymethylpyrrolidin-2-one 
• 58479-61-1 tert-butylchlorodiphenylsilane 
• 6893-26-1 D-Glutamic acid 
• 68766-96-1 ethyl (R)-2-pyrrolidone-5-carboxylate 
• 64700-65-8 methyl (2R)-pyroglutamate 

Downstream Products

• 138629-30-8 (5R)-5-(tert-butyldiphenylsilanyloxymethyl)-2-oxopyrrolidine-1-carboxylic acid tert-butyl ester 
• 1417743-71-5 (1R,3R,5R)-tert-butyl 3-((1-(4-(methoxycarbonyl)phenyl)cyclopropyl)carbamoyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate 
• 1417743-72-6 (1S,3R,5S)-tert-butyl 3-((1-(4-(methoxycarbonyl)phenyl)cyclopropyl)carbamoyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate 
• 138629-33-1 (S)-4-[(R)-4-((S)-4-Benzyl-2-oxo-oxazolidin-3-yl)-1-(tert-butyl-diphenyl-silanyloxymethyl)-4-oxo-butylcarbamoyl]-2-tert-butoxycarbonylamino-butyric acid benzyl ester 
• 138629-34-2 (S)-4-{1-Benzyl-4-[3-((S)-4-benzyl-2-oxo-oxazolidin-3-yl)-3-oxo-propyl]-1H-imidazol-2-yl}-2-tert-butoxycarbonylamino-butyric acid benzyl ester 
• 138629-47-7 (S)-4-[4-((S)-2-Acetylamino-2-methoxycarbonyl-ethyl)-1-benzyl-1H-imidazol-2-yl]-2-tert-butoxycarbonylamino-butyric acid benzyl ester 
• 138629-45-5 (S)-4-[(R)-4-((S)-4-Benzyl-2-oxo-oxazolidin-3-yl)-1-hydroxymethyl-4-oxo-butylcarbamoyl]-2-tert-butoxycarbonylamino-butyric acid benzyl ester 
• 138629-35-3 (S)-4-[4-((S)-2-Azido-2-methoxycarbonyl-ethyl)-1-benzyl-1H-imidazol-2-yl]-2-tert-butoxycarbonylamino-butyric acid benzyl ester 
• 138629-32-0 [(R)-4-((S)-4-Benzyl-2-oxo-oxazolidin-3-yl)-1-(tert-butyl-diphenyl-silanyloxymethyl)-4-oxo-butyl]-carbamic acid tert-butyl ester 

Relevant articles and documents

COMPOUNDS TARGETING RNA-BINDING PROTEINS OR RNA-MODIFYING PROTEINS

The invention relates to a compound represented by Formula (I): or a pharmaceutically acceptable salt thereof, compositions comprising the same and methods of preparing and using the same. The variables are described herein.

CYCLIC AMINE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS

There is described a novel group of cyclic amine derivative compounds, having an EP4 receptor antagonistic activity and specifically pharmaceutical compounds which are useful for the treatment or alleviation of Prostaglandin E mediated diseases. The present invention therefore relates to novel compounds which are selective antagonists of the EP4 subtype of PGE2 receptors with analgesic and antinflammatory activity, processes for their preparation, pharmaceutical compositions containing them and their use as medicaments, inter alia for the treatment or alleviation of Prostaglandin E mediated diseases such as acute and chronic pain, osteoarthritis, inflammation-associated disorder as arthritis, rheumatoid arthritis, cancer, migraine and endometriosis.

CYCLIC AMINE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS

There is described a novel group of cyclic amine derivative compounds, having an EP4 receptor antagonistic activity and specifically pharmaceutical compounds which are useful for the treatment or alleviation of Prostaglandin E mediated diseases. The present invention therefore relates to novel compounds which are selective antagonists of the EP 4 sub type of PGE2 receptors with analgesic and antinflammatory activity, processes for their preparation, pharmaceutical compositions containing them and theiruse as medicaments, inter alia for the treatment or alleviation of Prostaglandin E mediated diseases such as acute and chronic pain, osteoarthritis, inflammation-associated disorder as arthritis, rheumatoid arthritis, cancer, migraine and endometriosis.